CNS activity of ensartinib in ALK+ non-small cell lung cancer (NSCLC) patients (pts)

Authors :: K. Harrow
Sandip Pravin Patel
Joel W. Neal
Barbara J. Gitlitz
Karen L. Reckamp
Saiama N. Waqar
George R. Blumenschein
Leora Horn
Heather A. Wakelee
F. Tan
Source :: Annals of Oncology. 28:ii31-ii32
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: 0301 basic medicine
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Oncology
business.industry
030220 oncology & carcinogenesis
Cancer research
medicine
non-small cell lung cancer (NSCLC)
Hematology
medicine.disease
business

Tools